References
- 1. Xiang P, Xu M, Gao I, et al. First case of 2019 novel coronavirus disease with encephalitis. ChinaXiv T200003.00015, 2020.
- 2. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/ encephalitis associated with SARS-Coronavirus-2. Int J Inf Dis 2020; 94: 55-58.
- 3. Lau K, Yu C, Chu M, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004; 10: 342-344.
- 4. Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis 2005; 41: 1089-1096.
- 5. Steardo L Jr, Steardo L, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol 2020a; 229e:13473.
- 6. Zhou Z, Kang H, Li S, et al. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Nerol 2020; 267: 2179-2184.
- 7. Tremblay M-E, Madore C, Bordeleau M, et al. Neuropathology of COVID-19 the role of glia. Front Cell Neurosc 2020; 14: 592214.
- 8. Al-Sarraj S. Troakest C, Hanley B, et al. Invited Review: The spectrum of neuropathology in COVID-19. Neuropathol Appl Neurobiol 2021; 47: 3-16.
- 9. William R. A review on string vessels or collapsed, empty basement membrane tubes. J Alzheimer Dis 2010; 21: 725-739.
- 10. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368:m1091.
- 11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
- 12. Mao L, Jin H, Wang M, et al. Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-690.
- 13. Costello F, Dalakas C. Cranial neuropathies and COVID-19: neurotropism and autoimmunity. Neurology 2020; 95: 195-196.
- 14. Ellul A, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19: 767-783.
- 15. Hosseini A, Shetty K, Spring N, et al. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy? Brain Behav Immun. 2020; 88: 68-70.
- 16. Rogers P, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systemic review ant meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7: 611-627.
- 17. Dalmau J, Tuzun E, Wu Y, et al. Paraneoplastic anti-N-methyl- D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
- 18. Granerod J, Ambrose E, Davies W, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect 2010; 10: 835-844.
- 19. Crisp J, Kullmann M, Vincent A. Autoimmune synaptopathies. Nat Rev Neurosci 2016; 17: 103-117.
- 20. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020; 382: e38.
- 21. Stoyanov GS, Petkova L, Dzhenkov DL, et al. Gross and histopathology of COVID-19 with first histology report of olfactory bulb changes. Cureus 2020: 12(12): e11912. DOI 10.7759/cureus.11912.
- 22. Vargas-Gandica J, Winter D, Schnippe R, et al. Ageusia and anosmia: a common sign of COVID-19? A case series from four countries. J Neurovirol 2020; 26:785-789.
- 23. Cooper KW, Brann DH, Farruggia MC, et al. COVID-19 and chemical senses: supporting players take center stage. Neuron. 2020; 107:219-233.